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ABSTRACT
Pelvic inflammatory disease (PID) is a serious public health and reproductive health problem in the
United States. An early and accurate diagnosis of PID is extremely important for the effective
management of the acute illness and for the prevention oflong-term sequelae. The diagnosis ofPID
is difficult, with considerable numbers of false-positive and false-negative diagnoses. An abnormal
vaginal discharge or evidence of lower genital tract infection is an important and predictive finding
that is often underemphasized and overlooked. This paper reviews the clinical diagnosis and sup-
portive laboratory tests for the diagnosis ofPID and outlines an appropriate diagnostic plan for the
clinician and the researcher. (C) 1994 .Wiley-Liss, Inc.
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n early and accurate diagnosis of pelvic inflam-
matory disease (PID) is of paramount impor-
tance for the effective management of the acute
illness and for the prevention of long-term sequelae
such as infertility, ectopic pregnancy, chronic pel-
vic pain, and recurrent PID. The diagnosis of
PID, however, is problematic as patients often
present with minimal signs or symptoms and the
severity of clinical signs varies widely. The chang-
ing etiologic, epidemiologic, and clinical profile of
the disease magnifies this difficulty. Patients with
PID may have minimal pain and atypical symp-
toms and remain undiagnosed, or they may be mis-
diagnosed as having gastrointestinal or noninfec-
tious gynecologic illnesses.
1-s Undiagnosed PID
results in failure to treat or delay of treatment,
which has been associated with an increased risk of
long-term sequelae.
6-8
CASE ILLUSTRATION
A 20-year-old university undergraduate presented
to a medical clinic for evaluation of burning with
urination and abdominal discomfort. Symptoms of
abdominal and pelvic discomfort and dysuria be-
gan 1-2 days prior to evaluation. The patient had
never been pregnant, had no significant medical or
surgical history or history of sexually transmitted
diseases (STDs), used condoms for contraception,
and was in a monogomous relationship for the past
2-3 years.
The practitioner evaluating the patient noted white
blood cells (WBCs) in the clean-catch urinalysis
and abdominal tenderness on examination. No pel-
vic examination or cultures were performed. The
patient was diagnosed with a urinary tract infection
and was told she might also have PID. She was
given a prescription for ofloxacin, 300 mg b.i.d.,
which she filled and started immediately.
The patient followed-up with the student health
clinic and was seen by a nurse practitioner 2 days
later. On pelvic examination, she was noted to have
abdominal, cervical motion, and adnexal tender-
ness. She was told that her examination was consis-
tent with PID, and her prescription was changed to
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ofloxacin, 400 mg b.i.d., and metronidazole, 500
mg b.i.d., for 14 days. Instructions were given to
have her sexual partner evaluated and treated.
Concerned with a 2-week course of antibiotic
therapy and the implication of an STD, the patient
sought consultation with a gynecologist, then 5 days
after the onset of symptoms. By this time, her
symptoms were almost resolved with the exception
of mild vulvar pruritus. On examination at this
evaluation, she had a cloudy-white discharge in the
vaginal vault but no abdominal or pelvic tender-
ness. The vaginal pH was 4.2. Microscopic evalu-
ation of the discharge revealed no WBCs, trich-
omonads, or clue cells; occasional pseudohyphae
were noted. She was given a prescription for can-
didal vaginitis and was told to continue her course
of antibiotics for "presumed" PID. The patient had
numerous questions regarding her diagnosis, prog-
nosis, and therapy.
This case illustrates the difficulties encountered
in the routine diagnosis of PID. Many primary
practitioners are reluctant to perform a pelvic ex-
amination. In addition, the importance of evaluat-
ing the vaginal discharge is illustrated in this exam-
ple. Was the urine contaminated with excess vaginal
WBCs secondary to a lower genital tract infection?
Was the pyuria the result of inflammation of the
bladder due to infection of the pelvic organs adja-
cent to the bladder? Or was the vaginal discharge
normal and the patient had a case of urethritis and
cystitis? A simple saline preparation of the vaginal
discharge would add important diagnostic informa-
tion.
PROBLEMS WITH THE CLINICAL
DIAGNOSIS OF PID
The clinical diagnosis of PID based on a bimanual
pelvic examination and traditional laboratory test-
ing has serious limitations.9’1 Both overdiagnosis
and underdiagnosis are quite common, and the list
of conditions that must be considered in the differ-
ential diagnosis of PID is extensive (Table 1).
Jacobson and Westrom
3 noted that one-third of
women with the clinical diagnosis of PID have
been misdiagnosed. Twelve percent were found to
have other pathology such as appendicitis, endo-
metriosis, hemorrhagic corpus luteum, or ectopic
pregnancy; 23% were normal upon laparoscopic
evaluation.
3 Laparoscopic evaluation of patients
with other clinical diagnoses can also reveal unsus-
TABLE I. Differential diagnosis of PID
Acute appendicitis
Ectopic pregnancy
Endometriosis
Ovarian cyst or tumor
Hemorrhage
Rupture
Torsion
Peritonitis
Pyelonephritis
Ruptured or perforated viscus
Intraperitoneal hemorrhage
Generalized sepsis
Urinary tract infection
Uterine myoma
Pelvic adhesions
Chronic salpingitis
Acute gastrointestinal inflammation
Miscellaneous
pected PID. By using more stringent criteria for
the diagnosis, such as the presence of fever or leu-
kocytosis; the specificity of the diagnosis can be
increased. However, this increase in specificity will
result in a marked reduction in sensitivity.
10,11
The limitations of the clinical diagnosis of PID
underscore the need for more accurate diagnostic
techniques that are widely available and cost-effec-
tive.
12 What follows is a critical review of the
current techniques used in the clinical diagnosis of
PID, including historical risk factors, physical ex-
amination, laboratory testing, and more elaborate
tests such as endometrial biopsy, endovaginal ultra-
sonography, and laparoscopy. As these data are re-
viewed, the reader should consider how the accu-
rate diagnosis ofPID can be made with concer.n for
both patient and health-care costs.
HISTORIC RISK FACTORS AND
RISK MARKERS
From case-control studies in the United States of
women with confirmed PID, the patients with PID
were younger, more often nonwhite, single, unem-
ployed, had less education, consumed more alco-
hol, were more likely to use tobacco, and were
more likely to douche than a sexually active control
group without PID.
1, 14 They also initiated sexual
activity earlier, reported a higher number of life-
time sexual partners, had intercourse more fre-
quently, had frequent change of sexual partners,
and reported a history of Neisseria gonorrhoeae,
Chlamydia trachomatis, or PID more often than did
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controls. In addition, cases with proven PID were
less likely than control subjects to use any birth-
control method.
13
Health-care behavior impacts on the risk of ac-
quiring PID. The risk of an upper genital tract
infection increases when there is late medical con-
sultation for the diagnosis and treatment of STDs,
when there is noncompliance with medical therapy,
and when the sexual partner is not treated.
13
Contraceptive history influences the occurrence
of PID. Studies have shown that barrier methods
may decrease the risk of PID, presumably by pro-
tecting against cervical infection, is The intrauter-
ine device (IUD) may be associated with an in-
creased risk of PID, but his risk appears to be
limited to the 1st several months after IUD inser-
tion.
16-8 However, women at low risk of acquir-
ing an STD have little increased risk of PID with
IUD use.
19 A tubal ligation markedly decreases the
risk of ascending infection from the lower genital
tract.
2 The literature is unclear with regard to the
effect of oral contraceptives on the risk of PID. It
would appear that, while the use of oral contracep-
tives increases a woman’s risk for chlamydial endo-
cervical infection, it decreases the risk of develop-
ing overt PID. In addition, women using oral
contraceptives with laparoscopically proven salpin-
gitis tend to have a milder stage of disease. It is
unclear whether or not the oral contraceptives pre-
vent "silent salpingitis." Numerous human and an-
imal studies exist,
21-29 yet the impact of oral con-
traceptives on PID remains unclear due to
numerous confounding behavioral variables in this
complex relationship. Additional studies are needed
to sort out this association.
While epidemiologic risk factors and risk mark-
ers may be helpful in determining who is at an
increased risk ofPlD, these factors may play only a
small role in the diagnosis of an individual patient.
In general, women at risk for contracting an STD
are at risk to develop PID.
SYMPTOMS
Numerous symptoms are associated with upper gen-
ital tract infection. Pelvic pain is one of the most
common complaints encountered in gynecology and
may represent PID. Pain associated with PID is
most often described as dull, continuous, low ab-
dominal or bilateral pelvic in location, and gradual
in onset. In gonococcal PID, the pain is often more
TABLE 2. Prevalence of symptoms in cases of
laparoscopically proven PID
Symptom Percent
Abnormal vaginal discharge 55-75
Reported elevated temperature 35-45
Irregular bleeding 30-35
Urinary symptoms 15-20
Chills 0-15
Nausea and vomiting 5-I 0
Anorectal symptoms 5-I 0
Right upper-quadrant pain 5
intense, and medical consultation is sought usually
within a few days. In contrast, chlamydial PID is
less intense, and the patient may wait a week or
longer prior to seeking medical attention. In
"asymptomatic salpingitis," or "atypical PID," pain
may not be present.
Symptoms typically occur during menstruation
or the proliferative phase, rather than the luteal
phase of the cycle. 9’1 Abnormal uterine bleeding,
including intermenstrual bleeding and menorrha-
gia, is correlated with histologic evidence of en-
dometritis.
2 These symptoms were reported by
one-third of laparoscopically proven cases of acute
salpingitis.
3 Menorrhagic or intermenstrual
bleeding is more common in chlamydial PID than
in cases of gonorrhea-associated or non-STD-asso-
ciated PID.
Among cases of women with proven salpingitis
who recorded their temperature prior to consulting
medical care, 40% reported febrile illness.
9 Chills
were reported by 12%. A vaginal discharge has
been considered a hallmark of PID. Three-
fourths of women with laparoscopically verified
PID gave a history of an abnormal vaginal dis-
charge, and all women with salpingitis had an ab-
normal discharge on physical examination.3’4
Urinary symptoms, such as frequency or a burning
sensation, were present in 15-20% of laparoscopi-
cally verified PID.
9 Gastrointestinal symptoms are
uncommon in mild or moderate salpingitis, but
nausea and vomiting are common complaints in
severe PID. Symptoms of proctitis are infre-
quent; if present, these symptoms should raise a
suspicion of a cul-de-sac abscess or gonoccoccal
proctitis.
9 The frequency of various symptoms in
cases of laparoscopically proven PID is presented
in Table 2.
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In summary, numerous genitourinary tract
symptoms occur in patients with PID. Pain may or
may not be present. Since no symptom has signifi-
cant specificity or sensitivity with respect to the
diagnosis of PID, patients with any genitourinary
symptoms should be considered candidates for the
diagnosis.
PHYSICAL EXAMINATION
Hagdu et al.
3s used multivariate logistic regression
analysis to identify important predictors of PID.
The most important predictor ofPID was found to
be an abnormal vaginal discharge which was found
in virtually all women with salpingitis. The impor-
tance of a careful assessment for mucopurulent cer-
vicitis and cervical inflammation and an evaluation
of the vaginal discharge cannot be overstated.
Bacterial vaginosis also has been found to be an
independent risk factor for PID. In a study of
women with suspected PID, bacterial vaginosis was
found in 9/31 women with proven PID and 0/14
without PID.
36 In a recent study of the microbio-
logic etiology of acute salpingitis, an abnormal vag-
inal flora characterized by bacterial vaginosis or its
intermediate state was almost always present in pa-
tients with acute salpingitis. The authors noted that,
other than N. gonorrhoeae and C. trachomatis, bac-
terial vaginosis microorganisms were the most com-
mon group of microorganisms isolated from the
upper genital tract.
37 In contrast, Faro and col-
leagues
38 did not find this association in their study
of 41 women with clinically severe PID.
Leukorrhea is present when inflammatory cells
[polymorphonuclear (PMN) leukocytes] are the
predominant cells noted during microscopy of a
vaginal saline preparation. Microscopic evaluation
of the vaginal secretion is a simple and rapid test
that can provide valuable information in the diag-
nosis of PID.
3s The proportion of inflammatory
cells indicates the degree of host response. A nor-
mal wet mount of the vaginal secretions, plus clear
cervical mucus, is felt to reliably exclude upper
genital tract infection.
3 The presence of a mu-
copurulent cervical discharge is defined as endocer-
vical mucopus or the presence of> 10 PMN leuko-
cytes per high power field ( 1,000) in Gram-
stained endocervical smears.
39 The presence of
leukorrhea or mucopus is consistent with the diag-
nosis of lower genital tract infection. Leukorrhea
or mucopurulent cervicitis is suggestive of PID in
TABLE 3. Sensitivities and specificities of selected
physical examination findings
Sign Sensitivity (%) Specificity (%)
Adnexal tenderness
2 95 74
Bilateral tenderness12 58 92
Cervical motion tendernessa 82 72
Palpable massa 48 75
Abdominal guarding
4 64 63
Clinical cervicitis
4 75 93
women with coexisting pelvic pain or pelvic organ
tenderness.
9,4
Kahn and colleagues
12 evaluated data on the di-
agnosis ofPID and combined data from 14 studies
for review. Adnexal tenderness had a high sensitiv-
ity (95%), but a low specificity (74%) in predicting
PID. Other sensitivities and specificities of physi-
cal examination findings based on this review
12 and
a recent study from a primary care setting
4 are
presented in Table 3.
Since the treatment of a tubo-ovarian abscess
(TOA) requires hospitalization, the presence of a
palpable adnexal mass is an important clinical find-
ing. The clinical diagnosis of a TOA is based on
clinical criteria for PID in conjunction with a pal-
pable adnexal complex. The predictive value of a
palpable mass, however, is low as this finding was
reported by experienced examiners in 25% of cases
with normal findings at laparoscopy.
9 Ultrasound
may be useful to further characterize the mass.
Other signs, symptoms, and laboratory tests are not
helpful in the diagnosis of a TOA.
LABORATORY TESTING
There is no one diagnostic test that is pathogno-
monic for PID. Several new tests have been pro-
posed in the evaluation and diagnosis of women
with suspected upper genital tract infection. These
tests include C-reactive protein (CRP),’42-4s en-
dometrial biopsy,2’6’45-47 and endovaginal ultra-
sound.
48-52 It is clearly important to develop and to
carefully evaluate these and other diagnostic tests
that would improve and facilitate the diagnosis of
PID. For the sake of brevity, only a few of the
more predictive laboratory tests will be reviewed.
In 4 of 4 studies reviewed by Kahn et al.,
12 an
elevated CRP was found to be a significant predic-
tor. Sensitivities ranged from 74 to 93%, and spec-
ificitie ranged from 50 to 90%.
30,42-45 In addi-
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 41PID DIAGNOSIS PEIPERT AND SOPER
tion, levels ofCRP appear to reflect the severity of
laparoscopically proven salpingitis. The ability of a
microbial substance to stimulate the synthesis of
hepatic acute-phase proteins such as CRP is a prom-
inent pathophysiologic mechanism of PID.
3
Westrom
3 noted an elevated erythrocyte sedi-
mentation rate (ESR) >15 mm/h in 76% of pa-
tients with visually diagnosed acute salpingitis, but
also in 53% of women with suspected salpingitis
but normal findings at laparoscopy. A significant
association was noted between the ESR and the
stage of salpingitis at laparoscopy and with chlamy-
dia-associated salpingitis. When comparing ESR
and CRP, Wasserheit et al.
4 found that an ele-
vated CRP was a more sensitive and specific pre-
dictor ofPID than was ESR.
Despite widespread belief by clinicians, an ele-
vated WBC count is not a reliable predictor of
PID, nor does it correlate with the severity of tubal
inflammation or need for hospitalization. In fact,
fewer than 60% ofwomen with a laparoscopic diag-
nosis of acute salpingitis have a WBC count
> 10,000 cells/ml. 9
Even though no one diagnostic test is pathogno-
monic for PID, it would appear that CRP has
sufficient predictive value to be utilized in the di-
agnosis of PID. Additional studies are necessary to
determine if CRP remains predictive in cases of
mild and atypical PID.
MICROBIOLOGIC TESTING
N. gonorrhoeae has been called the "classic" PID-
causing agent.
9 In studies from the United States
and Canada, N. gonorrhoeae has been isolated from
the lower genital tract in 44-70% of women with
acute PID, depending on diagnostic inclusion cri-
teria.
9 Isolation of gonococci from the upper geni-
tal tract of patients with PID is usually between 10
and 54%.
37,53,54 Based on culture or serologic evi-
dence, infection with C. trachomatis may be present
in up to 38%ss of hospitalized cases and 52% of
women treated as outpatients for PID.
s6,s7
Positive tests for N. gonorrhoeae or C. trachoma-
t/s also have been found to be significant predictors
of PID in 2 well-designed studies.s’4 Studies
evaluating the identification ofmicroorganisms and
the diagnosis of PID are often limited by the mi-
crobiologic technique used for identification. While
culture has traditionally been the gold standard for
the diagnosis of both gonorrhea and chlamydia,
recent studies have shown that the polymerase chain
reaction (PCR) assay may be a more sensitive
method, sS’s9 PCR is not only sensitive, but is
highly specific. In a study evaluating 15 women
with laparoscopically verified salpingitis, Witkin
et al.
6 found 60% (9/15) had positive PCR testing
for chlamydia. Only 2 of these positive results had
positive cervical cultures. The authors
6 concluded
that PCR is a more sensitive and more rapid test for
C. trachomatis in this population of women with
acute salpingitis.
Evidence of lower genital tract infection, either
by microbiologic testing or by evaluation of cervi-
cal Gram stain or vaginal discharge, is a hallmark
of upper genital tract infection. In fact, the clinical
diagnosis of PID is suspect in women who do not
test positive for N. gonorrhoeae or C. trachomatis or
who fail to show evidence of lower genital tract
inflammation.
ENDOMETRIAL BIOPSY
An endometrial biopsy can be a useful alternative to
laparoscopy as an objective test in the diagnosis of
PID. 32’36’46’47 It is a simple office or outpatient
procedure that can be performed with or without a
paracervical anesthetic. Endometrial sampling can
be obtained with a variety of devices. A Novak
curette, a VABRA (Berkeley Medevices, Inc., Ber-
keley, CA) endometrial suction curette, or a flexi-
ble endometrial sampling device such as the Pipelle
(Unimar, Inc., Danbury, CT) or Gynosampler
(Gynopharma, Inc., Somerville, NJ) can be used.
The histopathologic diagnosis is usually available in
3-4 days. If an endometrial biopsy is used for
histologic evaluation and culture of the upper geni-
tal tract in patients with suspected upper genital
tract infection, antibiotics should be administered
immediately after the sample is obtained.
The histologic features of the endometrium that
are associated with infection of the upper genital
tract and laparoscopically proven salpingitis include
the presence ofPMN leukocytes in the endometrial
surface epithelium, dense subepithelial stromal lym-
phocytic infiltration, germinal centers containing
transformed lymphocytes, and plasma cells in the
41,55,61 endometrial stroma.
Recent studies have shown a fair correlation be-
tween endometritis as demonstrated histologically
and the laparoscopic diagnosis of PID.6’47 En-
dometrial inflammation on biopsy has a good sensi-
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tivity (70-92%) and specificity (67-89%) for the
diagnosis of PID. 43’44’55 Using a definition of
histologic endometritis of > plasma cell/ 120
field in the endometrial stroma plus >5 PMN
leukocytes/X400 field in the endometrial surface
gave the best prediction of laparoscopically proven
salpingitis. This combination of histologic findings
gave a sensitivity of92% and a specificity of 87%.
61
Sellors and colleagues
41 demonstrated that an en-
dometrial biopsy was more than 90% specific in
predicting histopathologic evidence of salpingitis.
Additional prospective studies are necessary in
women with classic PID (with pain) and atypical
PID (without pain) to confirm the predictive val-
ues of histopathologic criteria for endometritis in
diagnosing patients with suspected upper genital
tract infection.
An endometrial biopsy is also an indispensable
tool in evaluating the endometrium of patients un-
dergoing laparoscopy. If laparoscopic findings are
not consistent with visual criteria for salpingitis,
acute or chronic endometritis may be the source of"
the patient’s symptoms.
An endometrial evaluation with outpatient sam-
pling devices is an underutilized procedure in the
diagnosis of upper genital tract infection. Histo-
logic evidence of endometritis confirms the pres-
ence of upper genital tract inflammation and sup-
ports the diagnosis of PID.
ULTRASONOGRAPHY
Transabdominal ultrasonography is useful in iden-
tifying complicated PID, e.g., TOA or inflamma-
tory complex, but has not been very effective in
distinguishing uncomplicated PID from other gy-
necologic conditions such as endometriosis or ova-
rian cysts.
62-64 The use of endovaginal probes has
refined the imaging of the pelvic organs. 48’49
Transvaginal ultrasonography is a relatively nonin-
vasive diagnostic modality that can be combined
with the pelvic examination for evaluating gyneco-
logic disorders, including PID. s’sl
In a recent prospective study of 51 women with
suspected PID, Cacciatore et al.
s2 demonstrated
that a transvaginal sonogram suggestive of PID,
e.g., thickened, fluid-filled tubes, had a sensitivity
of 85% and a specificity of 100% for the diagnosis
of plasma cell endometritis as determined by an
endometrial biopsy. The positive and negative pre-
dictive values for the group were 100 and 95%,
respectively. The authors
52 concluded that trans-
vaginal sonography can aid in the outpatient evalu-
ation of women with suspected PID.
The findings of Cacciatore and colleagues
s2
should be validated in other cohorts ofwomen with
both mild and severe cases of PID. As clinicians
gain more experience with transvaginal sonogra-
phy, this technique may become useful in evaluat-
ing patients with the presumptive diagnosis ofPID.
CLINICAL CRITERIA FOR PID
Clinical criteria for the diagnosis ofPID have been
outlined on several occasions
6s-68 and are listed in
Table 4. The Centers for Disease Control and Pre-
vention (CDC) has released revised clinical criteria
for PID which are summarized in Table 5.
68
Jacobson and Westrom
3 evaluated the accuracy
of conventional signs and symptoms of PID as
assessed by visual confirmation of acute salpingitis.
Diagnostic accuracy could be improved by increas-
ing the number of positive parameters. They also
noted that a marked increase in the number of
inflammatory cells in the wet smear of vaginal se-
cretions was found in women with PID. This test
could be used to exclude the possibility of PID in
women with abdominal pain.
Criteria endorsed by the Infectious Disease Soci-
ety for Obstetrics and Gynecology (IDSOG) have
been outlined by Hager et al.
6s The IDSOG guide-
lines eliminate the previously required chief com-
plaint of abdominal pain. This is an important
improvement if we are interested in patients with
atypical PID who may not have abdominal pain.
Soper
67 proposed a set of clinical criteria that
was a compromise between the 2 previously pub-
lished guidelines. In these guidelines, the impor-
tance of signs of lower genital tract infection is
stressed. In addition, the endometrial biopsy is pro-
posed as an adjunct to confirm the clinician’s suspi-
cion of upper genital tract infection.
The CDC’s minimum clinical criteria for PID
include abdominal tenderness, cervical motion ten-
derness, and adnexal tenderness.
68 Based on the
presence of all 3 of these findings, empiric treat-
ment of PID should be instituted in the absence of
an established cause other than PID. The additional
criteria listed are proposed for patients with severe
clinical signs in whom incorrect diagnosis and man-
agement may cause unnecessary morbidity.
Unfortunately, the clinical criteria proposed have
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TABLE 4. Clinical criteria for the diagnosis of PID
Hager et al.
6s Swee[66 Soper
67
Abdominal tenderness
Cervical motion tenderness
Adnexal tenderness
Major Criteria (All Must Be Present)
Abdominal tenderness
Cervical motion tenderness
Adnexal tenderness
Adnexal tenderness
Signs of lower genital tract infection
Minor Criteria (Additional Criteria Increase the Specificity of the Diagnosis)
Endocervical Gram stain positive for
N. gonorrhoeae
Temperature >38C
Leukocytosis (> I0,000)
Purulent material by culdocentesis
or laparoscopy
Pelvic abscess or inflammatory
complex on bimanual examination
or sonography
>5 WBCs/ 1000 fieldgram on
gram stain of endocervix
Temperature >38C
Leukocytosis (> 10,500)
Purulent material by culdocentesis
Pelvic complex by examination or
sonography
Evidence of N. gonorrhoeae or C.
trachomatis in endocervix
(+Gram stain for N. gonorrhoeae
or monoclonal antibody for C.
trachomatis)
Histologic evidence of endometritis
Elevated CRP or ESR
Temperature 38C
Leukocytosis (> 0,000)
Positive test for C. trachomatis or
N. gonorrhoeae
TABLE 5. Revised CDC criteria for the diagnosis
of PID
Minimum
Lower abdominal tenderness
Adnexal tenderness
Cervical motion tenderness
Additional
Routine
Oral temperature >38.8C
Abnormal cervical or vaginal discharge
Elevated ESR
Elevated CRP
Laboratory documentation of cervical infection with
N. gonorrhoeae or C. trachomatis
Elaborate
Histopathologic evidence of endometritis on endometrial
biopsy
TOA on sonography or other radiologic tests
Laparoscopic abnormalities consistent with PID
never been adequately validated in large prospec-
tive studies.
12,68 When attempts have been made to
validate clinical criteria, the imprecision of clinical
diagnosis is clear. Approximately one-third of
women diagnosed with PID do not have PID when
laparoscopic inspection is performed.
3
LAPAROSCOPY
It is believed that PID is best diagnosed visually by
3,69,70 laparoscopic evaluation of the pelvic organs.
However, a diagnostic laparoscopy is expensive and
is not always readily available. In addition, many
women without visible salpingitis may have infec-
tion either within the tubal lumen or the endo-
metrium and therefore may have a false-negative
laparoscopy.2’37 At the time of diagnostic laparos-
copy, it is recommended that an endometrial biopsy
be performed to rule out endometritis that has not
progressed to acute salpingitis.
Three laparoscopic findings have been used as
the minimal criteria for the visual confirmation of
acute salpingitis: pronounced hyperemia of the tu-
bal surface; edema of the tubal wall; and sticky
exudate on the tubal surface and from the fimbri-
ated ends of the fallopian tubes when patent. The
severity of disease at laparoscopic evaluation corre-
lates with the development of long-term sequelae.
ATYPICAL PID
The classic picture of acute PID with abdominal,
cervical motion, and abdominal tenderness may rep-
resent a small proportion of the entire spectrum of
cases of PID. In fact, a growing body of evidence
suggests that acute PID with lower abdominal pain
as the chief complaint may represent the "tip of the
iceberg" and that large numbers of women with
relatively or completely painless upper genital tract
infections are undiagnosed. The majority ofwomen
with tubal factor infertility have no history of signs
or symptoms ofPID.
7-7 Wolner-Hanssen et al.
have estimated that there may be 4-6 cases of atyp-
ical PID for every case of classic or typical PID.
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These authors suggested that additional studies are
necessary to determine the prevalence of histopatho-
logic endometritis in women with mucopurulent
cervicitis and in women with menorrhagia.
Although PID is believed to be associated with
abdominal pain of recent onset, symptoms from
other organ systems may also be due to upper geni-
tal tract infection. Genital tract symptoms (mu-
copurulent cervicitis, vaginal discharge, abnormal
uterine bleeding, dysmenorrhea, or dyspareunia),
gastrointestinal symptoms (nausea, vomiting, or
proctitis), or urinary tract symptoms (dysuria, ur-
gency, or frequency) may all be associated with
PID.
Most PID studies address only the classic pre-
sentations of the disease and fail to evaluate women
with more atypical forms of the disease. Cates et
al.
74 have attempted to identify predictors of atypi-
cal PID and found that women with atypical PID
were demographically more like fertile control sub-
jects than were women with overt PID. Behavioral
characteristics of the atypical PID group were mid-
way between those of the overt PID group and the
fertile control group. The authors
74 concluded that
the clinical predictors of atypical PID remain elu-
sive. Clinicians should consider PID in the differ-
ential diagnosis of women with mucopurulent cer-
vicitis and abdominal pain and in patients with
unexplained uterine bleeding, dyspareunia, or atyp-
ical pelvic pain. Future prospective studies should
address women with atypical as well as typical pre-
sentations of upper genital tract infection.
DIAGNOSTIC APPROACH
For the clinician, the diagnosis of PID should be
considered in any woman of reproductive age who
has any genitourinary symptoms, a Clinicians
should have a high index of suspicion and a low
threshold for initiating treatment because the po-
tential for serious long-term reproductive sequelae
is great, even if the patient’s symptoms are mild.
A comprehensive diagnostic evaluation will in-
clude a careful history to illicit risk factors for
PID, as well as a pelvic examination, and careful
assessment for lower genital tract infection, includ-
ing tests for N. gonorrhoeae and C. trachomatis,
testing for mucopurulent cervicitis, and evaluation
of the vaginal wet preparation for leukocytes. Ad-
ditional laboratory tests that may be helpful include
ESR, CRP, and endometrial biopsy.
TABLE 6. Effect of adjunctive clinical criteria on the
specificity of the clinical diagnosis of PID
a
Criteria Specificity (%)
Major
Lower abdominal pain
Signs of lower genital tract infection
Bilateral adnexal tenderness
Minor
Fever
Palpable adnexal swelling
Leukocytosis
Elevated ESR or CRP
Positive test for N. gonorrhoeae
or C. trachomatis
Major criteria (all three)
Major + one minor
Major + two minor
Major + three minor
61
78
90
96
aAdapted from Mardh and Westrom.
The CDC suggests that the minimal criteria
needed for the diagnosis of PID are abdominal,
cervical motion, and adnexal tenderness.
68 The sen-
sitivity and specificity of these criteria are unknown
at this time and await further validation. It is im-
perative to evaluate the lower genital tract for evi-
dence of infection. We believe that evidence of any
pelvic organ tenderness and the presence of lower
genital tract inflammation can be used to make the
diagnosis of PID. If there is no evidence of lower
genital tract infection (normal cervical mucus and
no predominance ofWBCs in the vaginal wet prep-
aration), the likelihood ofPID is quite low.
The likelihood of PID increases as the number
of positive findings increase. Adjunctive criteria
for the diagnosis ofPID include elevated tempera-
ture, palpation of an adnexal complex, leukocyto-
sis, elevated ESR or CRP, purulent material ob-
tained by culdocentesis, and/or a positive test for a
lower genital tract infection with N. gonorrhoeae or
C. trachomatis. The specificity of the clinical diag-
nosis of PID increases to greater than 90% when 2
or more adjunctive criteria are present with find-
ings of pain, adnexal tenderness, and leukorrhea
(Table 6). More elaborate indicators (endometrial
biopsy or laparoscopy) should be employed when
the diagnosis is uncertain, when symptoms are se-
vere and misdiagnosis may result in serious mor-
bidity, or when the diagnosis of salpingitis in the
patient with a mild clinical presentation must be
confirmed.
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Patients should be informed of the level of un-
certainty in the clinical diagnosis ofPID and should
be given the option of more elaborate diagnostic
evaluation. The label of "PID" as an STD should
not be taken lightly by the clinician. This diagnosis
often calls for a frank discussion between the pa-
tient and her sexual partner. Patients often choose
to have more invasive testing when given the op-
tion in order to provide an accurate diagnosis. The
clinician should provide the patient with the facts
and allow the patient to play an active role in deci-
sions concerning further diagnostic testing.
CONCLUSIONS
The accurate diagnosis of PID is difficult, and the
ramifications of misdiagnosis may be quite serious.
A thorough evaluation for PID will include a care-
ful history and physical examination with attention
to evidence of lower genital tract infection based on
inspection and vaginal wet preparation. Supportive
laboratory evaluation may include an elevated ESR,
CRP, and positive cultures from the lower genital
tract. When numerous positive criteria are noted,
the diagnostic specificity is high and further sup-
portive evaluation may not be necessary.
Missing the diagnosis of PID (false negative)
usually has more detrimental results than a false-
positive diagnosis. Therefore, when PID is sus-
pected, prompt treatment should be initiated as
sensitivity is paramount. When additional specific-
ity is sought (fewer false positives), as in severe
cases when serious morbidity may result from mis-
diagnosis or when misdiagnosis results in consider-
able psychologic burden to the patient, then more
elaborate supportive criteria such as an endometrial
biopsy or a laparoscopy should be considered.
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